Immunogenic death of colon cancer cells treated with oxaliplatin (original) (raw)

• Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE et al. (2002). Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186: 1522–1525.
  Article CAS PubMed Google Scholar
• Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R et al. (2007a). The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 220: 47–59.
  Article CAS PubMed Google Scholar
• Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A et al. (2007b). Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13: 1050–1059.
  Article CAS PubMed Google Scholar
• Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M et al. (2000). TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187–191.
  Article CAS PubMed Google Scholar
• Blachere NE, Darnell RB, Albert ML . (2005). Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol 3: e185.
  Article PubMed PubMed Central Google Scholar
• Bouché, Castaing M, Etienne PL, Texereau P, Auby D, Bedenne L et al. (2007). Randomized strategical of chemotherapy in metastatic colorectal cancer (FFCD 2000–05): preliminary results. J Clin Oncol 25: 4069.
  Google Scholar
• Camus M, Tosolini M, Mlecnik B, Pages F, Kirilovsky A, Berger A et al. (2009). Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res 69: 2685–2693.
  Article CAS PubMed Google Scholar
• Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N et al. (2005). Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202: 1691–1701.
  Article CAS PubMed PubMed Central Google Scholar
• Castedo M, Coquelle A, Vitale I, Vivet S, Mouhamad S, Viaud S et al. (2006). Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis. Ann NY Acad Sci 1090: 35–49.
  Article CAS PubMed Google Scholar
• Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, Izagirre N et al. (2007). TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA 104: 16645–16650.
  Article PubMed PubMed Central Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C et al. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960–1964.
  Article CAS PubMed Google Scholar
• Hsu WM, Hsieh FJ, Jeng YM, Kuo ML, Chen CN, Lai DM et al. (2005). Calreticulin expression in neuroblastoma—a novel independent prognostic factor. Ann Oncol 16: 314–321.
  Article CAS PubMed Google Scholar
• Kelland L . (2007). The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7: 573–584.
  Article CAS PubMed Google Scholar
• Laane E, Tamm KP, Buentke E, Ito K, Khahariza P, Oscarsson J et al. (2009). Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ.
• Matzinger P . (2002). The danger model: a renewed sense of self. Science 296: 301–305.
  Article CAS PubMed Google Scholar
• Mehta AM, Jordanova ES, Kenter GG, Ferrone S, Fleuren GJ . (2008). Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 57: 197–206.
  Article CAS PubMed Google Scholar
• Muggia FM, Fojo T . (2004). Platinums: extending their therapeutic spectrum. J Chemother 16 (Suppl 4): 77–82.
  Article CAS PubMed Google Scholar
• Netea-Maier RT, Hunsucker SW, Hoevenaars BM, Helmke SM, Slootweg PJ, Hermus AR et al. (2008). Discovery and validation of protein abundance differences between follicular thyroid neoplasms. Cancer Res 68: 1572–1580.
  Article CAS PubMed Google Scholar
• Obeid M, Panaretakis T, Joza N, Tufi R, Tesniere A, van Endert P et al. (2007a). Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ 14: 1848–1850.
  Article CAS PubMed Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL et al. (2007b). Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13: 54–61.
  Article CAS PubMed Google Scholar
• Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R et al. (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353: 2654–2666.
  Article CAS PubMed Google Scholar
• Panaretakis T, Joza N, Modjtahedi N, Vitale I, Durchschlag M, Fimia GM et al. (2008). The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 15: 1499–1509.
  Article CAS PubMed Google Scholar
• Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC et al. (2009). Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 28: 578–590.
  Article CAS PubMed PubMed Central Google Scholar
• Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D et al. (2006). High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290: C917–C924.
  Article CAS PubMed Google Scholar
• Sancho D, Joffre OP, Keller AM, Rogers NC, Martinez D, Hernanz-Falcon P et al. (2009). Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458: 899–903.
  Article CAS PubMed PubMed Central Google Scholar
• Sancho D, Mourao-Sa D, Joffre OP, Schulz O, Rogers NC, Pennington DJ et al. (2008). Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 118: 2098–2110.
  Article CAS PubMed PubMed Central Google Scholar
• Savill J, Fadok V . (2000). Corpse clearance defines the meaning of cell death. Nature 407: 784–788.
  Article CAS PubMed Google Scholar
• Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P et al. (1999). Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 96: 14888–14893.
  Article CAS PubMed PubMed Central Google Scholar
• Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O et al. (2008). Immunogenic cancer cell death: a key-lock paradigm. Curr Opin Immunol 20: 504–511.
  Article CAS PubMed Google Scholar
• Toquet C, Jarry A, Bou-Hanna C, Bach K, Denis MG, Mosnier JF et al. (2007). Altered calreticulin expression in human colon cancer: maintenance of calreticulin expression is associated with mucinous differentiation. Oncol Rep 17: 1101–1107.
  CAS PubMed Google Scholar
• Wang D, Lippard SJ . (2005). Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4: 307–320.
  Article CAS PubMed Google Scholar
• Wright CA, Kozik P, Zacharias M, Springer S . (2004). Tapasin and other chaperones: models of the MHC class I loading complex. Biol Chem 385: 763–778.
  Article CAS PubMed Google Scholar
• Zeng G, Aldridge ME, Tian X, Seiler D, Zhang X, Jin Y et al. (2006). Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system. J Immunol 177: 3582–3589.
  Article CAS PubMed Google Scholar
• Zhang Y, Williams DB . (2006). Assembly of MHC class I molecules within the endoplasmic reticulum. Immunol Res 35: 151–162.
  Article CAS PubMed Google Scholar
• Zitvogel L, Apetoh L, Ghiringhelli F, Andre F, Tesniere A, Kroemer G . (2008). The anticancer immune response: indispensable for therapeutic success? J Clin Invest 118: 1991–2001.
  Article CAS PubMed PubMed Central Google Scholar